CASI Pharmaceuticals Inc. CASIF

0.13 (0.03) (18.75%) as of 25 Sep
Market cap
$12.4M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
5.63 16.09 30.77 51.34 48.57 66.37 54.25 85.12 43.49 27.09
Receivables
4.09 15.35 10.14 12.97 9.80 4.65 1.29 — — —
Inventory
1.60 5.25 15.88 6.14 1.91 1.36 4.54 0.28 — —
Other current assets
— — — — 1.69 1.65 3.22 7.16 0.32 0.36
Total current assets
13.46 39.58 59.34 73.42 61.97 74.03 64.72 92.57 43.81 27.45
Property, Plant, Equpment (Net)
6.97 7.87 9.24 11.83 12.71 2.06 0.99 1.75 1.05 0.23
Long-Term Investments
1.72 1.91 1.69 7.46 40.13 29.44 14.04 — — —
Goodwill and Intangible Assets (Total)
0.22 0.24 1.84 1.06 12.20 13.21 13.67 18.79 — —
Long-term assets (Other)
0.74 0.59 0.77 1.06 2.18 0.30 0.50 0.31 0.24 0.03
Total non-current assets
12.19 14.10 15.92 22.81 76.33 53.71 37.91 20.85 1.29 0.26
Total Assets
25.65 53.67 75.27 96.23 138.30 127.73 102.63 113.41 45.10 27.71
Notes Payable
— — — — — 0.47 — 1.50 — —
Accounts Payable
1.07 2.72 4.44 3.29 2.22 3.26 5.11 0.97 2.09 1.06
Accrued Expenses
24.17 15.34 12.29 11.82 10.96 3.42 2.83 1.41 0.75 0.25
Current Part of Debt
23.43 18.39 — — 2.17 0.83 1.18 1.50 — —
Current Part of Taxes to Pay
— — — 1.90 — — — — — —
Other current liabilities
1.00 — — — 6.23 2.08 1.65 1.41 2.97 0.25
Total current liabilities
49.67 36.45 16.73 17.01 13.19 7.98 7.95 3.87 5.06 1.32
Long Term Debt (Total)
— — 18.90 — 1.11 0.97 1.02 — 1.50 1.49
Non-current Revenue (Deferred)
— — — — 2.83 2.35 — — — —
Minority Interests
— — — 22.36 23.46 22.03 20.67 — — —
Non-current Liabilities (Other)
13.26 15.37 15.48 12.30 14.33 13.83 1.02 0.07 0.00 4.12
Total non-current liabilities
13.26 15.37 34.38 34.66 40.61 38.22 21.69 0.07 1.50 5.61
Total liabilities
62.93 51.82 51.10 51.66 53.80 46.19 29.64 3.95 6.56 6.93
Additional Paid In Capital
722.24 713.30 695.79 691.77 696.22 658.25 606.69 596.71 498.58 470.15
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 1.24 0.98 0.95 0.70 0.60
Retained Earnings
(748.13) (700.07) (660.82) (637.16) (605.64) (570.50) (523.91) (478.94) (452.70) (441.93)
Treasury Stock
9.60 9.60 9.60 9.33 8.03 8.03 8.03 8.03 8.03 8.03
Common Equity (Total)
(37.28) 1.85 24.16 44.57 84.50 81.54 73.00 109.46 38.54 20.78
Shareholders Equity (Total)
(37.28) 1.85 24.17 44.57 84.50 81.54 73.00 109.46 38.54 20.78
Shareholders Equity and Liabilities (Total)
25.65 53.67 75.27 96.23 138.30 127.73 102.63 113.41 45.10 27.71
Shares (Common)
20.56 15.49 13.38 13.46 13.98 12.39 9.78 9.53 6.98 6.02
Shareholders Equity (Tangible)
(37.50) 1.61 22.33 43.51 72.30 68.33 59.32 90.68 38.54 20.78
Net Debt
17.80 2.29 (11.87) (51.34) (45.30) (64.58) (52.04) (83.62) (41.99) (25.60)
Total Debt
23.43 18.39 18.90 — 3.27 1.79 2.20 1.50 1.50 1.49

Fold the line items

In millions of $ except per-share values · columns are period end dates